Rhenman & Partners Asset Management AB

Latest statistics and disclosures from Rhenman & Partners Asset Management AB's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Rhenman & Partners Asset Management AB consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Rhenman & Partners Asset Management AB

Companies in the Rhenman & Partners Asset Management AB portfolio as of the March 2022 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Eli Lilly & Co. (LLY) 3.5 $35M -27% 124k 286.37
Horizon Therapeutics Pub L SHS (HZNP) 3.5 $35M -20% 336k 105.21
Abbvie (ABBV) 3.1 $32M -41% 195k 162.11
UnitedHealth (UNH) 2.9 $30M -51% 58k 509.97
McKesson Corporation (MCK) 2.9 $29M -46% 95k 306.13
Jazz Pharmaceuticals Shs Usd (JAZZ) 2.8 $28M -37% 182k 155.67
Pfizer (PFE) 2.7 $27M -47% 523k 51.77
Cigna Corp (CI) 2.6 $27M -20% 112k 239.61
CVS Caremark Corporation (CVS) 2.3 $24M -42% 235k 101.21
Vertex Pharmaceuticals Incorporated (VRTX) 2.3 $23M -45% 90k 260.97
Anthem (ANTM) 2.2 $23M -52% 46k 491.22
Boston Scientific Corporation (BSX) 2.2 $23M -43% 510k 44.29
Abiomed (ABMD) 2.2 $23M +30% 68k 331.24
Alnylam Pharmaceuticals (ALNY) 2.1 $21M -25% 130k 163.29

Setup an alert

Rhenman & Partners Asset Management AB will file the next quarterly 13-HR in about 3 months. Would you like to be notified?

Johnson & Johnson (JNJ) 2.0 $20M -55% 113k 177.23
Regeneron Pharmaceuticals (REGN) 2.0 $20M NEW 29k 698.42
Cooper Cos Com New (COO) 1.9 $19M -15% 46k 417.59
Apellis Pharmaceuticals (APLS) 1.9 $19M -12% 377k 50.81
Merck & Co (MRK) 1.8 $19M -25% 225k 82.05
Medtronic SHS (MDT) 1.8 $18M -45% 160k 110.95
Tenet Healthcare Corp Com New (THC) 1.7 $18M -3% 203k 85.96
Intra Cellular Therapies (ITCI) 1.7 $17M -28% 280k 61.19
BioMarin Pharmaceutical (BMRN) 1.7 $17M -16% 220k 77.10
AmerisourceBergen (ABC) 1.6 $17M -50% 108k 154.71
Biohaven Pharmaceutical Holding (BHVN) 1.6 $16M -9% 136k 118.57
Intuitive Surgical Com New (ISRG) 1.6 $16M +31% 53k 301.68
Centene Corporation (CNC) 1.6 $16M -26% 187k 84.19
Axonics Modulation Technolog (AXNX) 1.5 $15M -23% 240k 62.60
Biontech Se Sponsored Ads (BNTX) 1.4 $15M NEW 85k 170.56
Thermo Fisher Scientific (TMO) 1.4 $14M -46% 24k 590.65
Align Technology (ALGN) 1.3 $13M +100% 30k 436.00
Harmony Biosciences Hldgs In (HRMY) 1.3 $13M +21% 268k 48.65
Mirati Therapeutics (MRTX) 1.2 $12M 150k 82.22
Inspire Med Sys (INSP) 1.2 $12M +2% 48k 256.69
Becton, Dickinson and (BDX) 1.2 $12M -51% 45k 266.00
Humana (HUM) 1.1 $12M -51% 27k 435.17
Shockwave Med (SWAV) 1.1 $11M +61% 55k 207.35
Cytokinetics Com New (CYTK) 1.1 $11M +96% 295k 36.81
Abbott Laboratories (ABT) 1.1 $11M -10% 90k 118.36
Privia Health Group (PRVA) 1.0 $11M -31% 398k 26.73
Gilead Sciences (GILD) 1.0 $10M -38% 170k 59.45
Danaher Corporation (DHR) 1.0 $10M -5% 34k 293.32
Neurocrine Biosciences (NBIX) 1.0 $9.8M -30% 105k 93.75
Xencor (XNCR) 0.9 $9.2M -23% 344k 26.68
Seagen (SGEN) 0.9 $8.8M -51% 61k 144.05
Veeva Sys Cl A Com (VEEV) 0.8 $8.1M -36% 38k 212.45
Iovance Biotherapeutics (IOVA) 0.8 $7.9M -20% 475k 16.65
Edwards Lifesciences (EW) 0.8 $7.7M -35% 65k 117.72
R1 Rcm (RCM) 0.7 $7.6M -48% 282k 26.76
Dynavax Technologies Corp Com New (DVAX) 0.7 $7.4M -9% 681k 10.84
Meiragtx Holdings (MGTX) 0.7 $6.9M +11% 500k 13.85
ImmunoGen (IMGN) 0.7 $6.8M -5% 1.4M 4.76
Teladoc (TDOC) 0.7 $6.6M -26% 92k 72.13
Guardant Health (GH) 0.6 $6.3M -52% 95k 66.24
Silk Road Medical Inc Common (SILK) 0.6 $6.2M -25% 150k 41.29
Glaukos (GKOS) 0.6 $6.1M -39% 105k 57.82
Novocure Ord Shs (NVCR) 0.6 $5.8M -42% 70k 82.86
Aerie Pharmaceuticals (AERI) 0.5 $5.4M -21% 589k 9.10
EXACT Sciences Corporation (EXAS) 0.5 $5.3M -30% 76k 69.92
Progyny (PGNY) 0.5 $5.1M 100k 51.40
Immunocore Hldgs Ads (IMCR) 0.5 $5.1M +89% 171k 29.90
Alkermes SHS (ALKS) 0.5 $4.7M -14% 180k 26.31
Health Catalyst (HCAT) 0.5 $4.7M -25% 180k 26.13
Esperion Therapeutics (ESPR) 0.4 $4.6M 982k 4.64
Goodrx Hldgs Com Cl A (GDRX) 0.4 $4.5M NEW 235k 19.33
Sangamo Biosciences (SGMO) 0.4 $4.4M 761k 5.81
Iveric Bio (ISEE) 0.4 $4.4M -25% 260k 16.83
1life Healthcare (ONEM) 0.4 $4.2M -29% 375k 11.08
Oak Street Health (OSH) 0.4 $4.0M -31% 150k 26.88
Revance Therapeutics (RVNC) 0.4 $3.9M NEW 198k 19.50
Rigel Pharmaceuticals Com New (RIGL) 0.4 $3.8M -15% 1.3M 2.99
Intellia Therapeutics (NTLA) 0.4 $3.6M NEW 50k 72.68
Accolade (ACCD) 0.3 $3.5M -4% 200k 17.56
Myovant Sciences (MYOV) 0.3 $3.3M 249k 13.32
Nektar Therapeutics (NKTR) 0.3 $3.3M -35% 614k 5.39
Phathom Pharmaceuticals (PHAT) 0.3 $3.2M +26% 235k 13.61
Biogen Idec (BIIB) 0.3 $3.2M -86% 15k 210.60
Phreesia (PHR) 0.3 $3.1M -5% 117k 26.36
Stereotaxis Com New (STXS) 0.3 $3.0M 797k 3.73
Viewray (VRAY) 0.3 $2.9M -5% 735k 3.92
Ionis Pharmaceuticals (IONS) 0.3 $2.6M -5% 71k 37.04
Essa Pharma Com New (EPIX) 0.3 $2.5M -2% 411k 6.18
Macrogenics (MGNX) 0.2 $2.5M -4% 287k 8.81
Olink Hldg Ab Sponsored Ads (OLK) 0.2 $2.5M 140k 17.66
G1 Therapeutics (GTHX) 0.2 $2.4M -2% 316k 7.60
Olema Pharmaceuticals (OLMA) 0.2 $2.1M 500k 4.26
Rapid Micro Biosystems Class A Com (RPID) 0.2 $2.0M +52% 300k 6.79
Pieris Pharmaceuticals (PIRS) 0.1 $909k 300k 3.03
Annexon (ANNX) 0.1 $683k 250k 2.73

Past Filings by Rhenman & Partners Asset Management AB

SEC 13F filings are viewable for Rhenman & Partners Asset Management AB going back to 2013

View all past filings